Valuation: Ainos, Inc.

Market Cap 98.21L 87.18L 81.58L 73.95L 1.4Cr 95Cr 1.41Cr 9.8Cr 3.81Cr 48Cr 3.69Cr 3.61Cr 155.26Cr P/E 2024
-0.29x
P/E 2025 -0.47x
Enterprise Value 2.04Cr 1.81Cr 1.69Cr 1.54Cr 2.9Cr 196.69Cr 2.92Cr 20Cr 7.92Cr 100.34Cr 7.66Cr 7.49Cr 322.56Cr EV / Sales 2024
701x
EV / Sales 2025 162x
Free-Float
25.12%
Yield 2024 *
-
Yield 2025 -
1 day-3.01%
1 week-3.01%
Current month+1.57%
1 month-19.38%
3 months-31.02%
6 months-10.42%
Current year-21.34%
1 week 1.22
Extreme 1.22
1.4
1 month 1.2
Extreme 1.2
1.6
Current year 1.2
Extreme 1.2
3.88
1 year 1.2
Extreme 1.2
4.44
3 years 1.2
Extreme 1.2
21.45
5 years 1.2
Extreme 1.2
450
10 years 1.2
Extreme 1.2
1,781.25
Manager TitleAgeSince
Chief Executive Officer 56 15/04/2021
Director of Finance/CFO 54 15/03/2024
Director TitleAgeSince
Director/Board Member 49 15/04/2021
Director/Board Member 54 15/04/2021
Director/Board Member 42 15/04/2021
Date Insider Type Main position Quantity % Market Cap. Importance
03/06/26 Buy

Director

2,000 0.0286%
28/05/26 Buy

Director

250 0.0036%
27/05/26 Buy

Director

2,000 0.0286%
Change 5-day change 1-year change 3-year change Capi.($)
-3.01%-3.01%-63.46%-91.55% 98.21L
-2.98%-3.24%+20.85%+31.84% 25TCr
-2.53%-5.16%+0.29%-0.58% 16TCr
-0.42%-2.42%-10.52%+39.53% 14TCr
-0.50%-4.35%-56.65%-18.36% 6.14TCr
-0.86%-0.40%+12.21%+19.78% 5.03TCr
+1.66%-1.55%-20.09%-20.26% 4.67TCr
-1.00%-3.36%+19.55%+53.45% 4.83TCr
+0.02%+1.26%-4.31%+40.76% 4.59TCr
-0.84%-1.47%+32.90%+64.08% 4.32TCr
Average -0.81%-2.09%-6.92%+11.87% 8.45TCr
Weighted average by Cap. -1.22%-2.77%+2.50%+23.30%

Financials

2024 2025
Net sales 20.73T 18.4T 17.22T 15.61T 29.48T 19.98L 29.69T 2L 80.44T 10.19L 77.81T 76.14T 32.77L 1L 1L 1L 93.49T 2L 1.2Cr 2L 12.39L 5L 61.06L 5L 5L 1.96Cr
Net income -1.49Cr -1.32Cr -1.23Cr -1.12Cr -2.11Cr -143.28Cr -2.13Cr -15Cr -5.77Cr -73Cr -5.58Cr -5.46Cr -234.97Cr -1.48Cr -1.31Cr -1.23Cr -1.11Cr -2.1Cr -142.39Cr -2.12Cr -15Cr -5.73Cr -73Cr -5.54Cr -5.43Cr -233.52Cr
Net Debt 81.07L 71.97L 67.35L 61.04L 1.15Cr 78Cr 1.16Cr 8.09Cr 3.15Cr 40Cr 3.04Cr 2.98Cr 128.17Cr 1.06Cr 93.94L 87.91L 79.68L 1.5Cr 102.02Cr 1.52Cr 11Cr 4.11Cr 52Cr 3.97Cr 3.89Cr 167.3Cr
Projected Income Statement - Annual - Ainos, Inc.
Logo Ainos, Inc.
Ainos, Inc. is a dual-platform AI and biotech company advancing SmellTech and immune therapeutics. Its AI Nose platform and smell language model (SML) digitize scent into Smell ID, a machine-readable data, powering applications across robotics, smart factories, and healthcare. It is also developing VELDONA, an oral low-dose interferon therapy targeting rare diseases, autoimmune diseases, infectious diseases, and animal health. Its pipeline includes drug candidates for treating oral warts for human immunodeficiency virus seropositive patients, Sjogren’s syndrome, and feline chronic gingivostomatitis, a cat oral infection. Its product pipeline includes VELDONA Pet, VELDONA human drugs, AI Nose - NISD co-development, AI Nose industrial and robotics application, VOC POCT, VOC POCT Ainos Pen, VOC POCT CHS430, and Synthetic RNA (SRNA). VOC POCT-Ainos Pen is a device intended to be a cloud-connected, multipurpose, portable breath analyzer that is intended to monitor health conditions.
Employees
41
Date Price Change Volume
07/26/07 $1.290 -3.01% 45,009
05/26/05 $1.330 -1.70% 30,297
02/26/02 $1.353 +4.08% 51,186
01/26/01 $1.300 +2.36% 41,898
30/26/30 $1.270 +2.42% 1,36,979
  1. Stock Market
  2. Stocks
  3. AIMD Stock